These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27917671)

  • 1. [The role of oxidative stress in the development of diabetic neuropathy].
    Sztanek F; Molnárné Molnár Á; Balogh Z
    Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding the role of oxidative stress in diabetic neuropathy.
    Shakeel M
    Diabetes Metab Syndr; 2015; 9(4):373-8. PubMed ID: 25470637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic neuropathy and oxidative stress: therapeutic perspectives.
    Hosseini A; Abdollahi M
    Oxid Med Cell Longev; 2013; 2013():168039. PubMed ID: 23738033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic neuropathy and oxidative stress.
    Pop-Busui R; Sima A; Stevens M
    Diabetes Metab Res Rev; 2006; 22(4):257-73. PubMed ID: 16506271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment.
    Lin Q; Li K; Chen Y; Xie J; Wu C; Cui C; Deng B
    Mol Neurobiol; 2023 Aug; 60(8):4574-4594. PubMed ID: 37115404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the mechanisms of diabetic neuropathy.
    Vincent AM; Feldman EL
    Rev Endocr Metab Disord; 2004 Aug; 5(3):227-36. PubMed ID: 15211094
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
    Figueroa-Romero C; Sadidi M; Feldman EL
    Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of carbonyl stress in the development of diabetic complications].
    Makk-Merczel K; Szarka A
    Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.
    van Dam PS
    Diabetes Metab Res Rev; 2002; 18(3):176-84. PubMed ID: 12112935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration on the relationship between diabetic peripheral neuropathy and oxidative stress QU ling and].
    Qu L; Liang XC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):764-8. PubMed ID: 17879547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
    Hussain N; Adrian TE
    Curr Diabetes Rev; 2017; 13(5):488-497. PubMed ID: 27341846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin: A potential drug in the management of diabetic neuropathy.
    Suarez-Mendez S; Tovilla-Zárate CA; Juárez-Rojop IE; Bermúdez-Ocaña DY
    Biomed Pharmacother; 2018 Sep; 105():956-961. PubMed ID: 30021390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic neuropathy and other diabetic complications at the Diabetic Neuropathy Center of the University of Debrecen].
    Sztanek F; Balogh B; Molnár Á; Zöld E; Tóth N; Jakab AÁ; Paragh G
    Orv Hetil; 2020 Jul; 161(30):1243-1251. PubMed ID: 32653867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of miR-25 aggravates diabetic peripheral neuropathy.
    Zhang Y; Song C; Liu J; Bi Y; Li H
    Neuroreport; 2018 Aug; 29(11):945-953. PubMed ID: 29877948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of advanced glycation end products and their receptors in development of diabetic neuropathy.
    Wada R; Yagihashi S
    Ann N Y Acad Sci; 2005 Jun; 1043():598-604. PubMed ID: 16037282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucotoxic Mechanisms and Related Therapeutic Approaches.
    Yagihashi S
    Int Rev Neurobiol; 2016; 127():121-49. PubMed ID: 27133148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.
    Shen H; Zhao J; Liu Y; Sun G
    J Diabetes Res; 2018; 2018():3458615. PubMed ID: 30116739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.